![William Graham Richards](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
William Graham Richards
Gründer bei
Oxford Drug Design Ltd.
Profil
William Graham Richards is the founder of Oxford Drug Design Ltd. (founded in 2001) and serves as the Chairman.
Mr. Richards is also the founder of Oxford Molecular Group Plc.
Current job: Advisor at o2h Ltd.
Former jobs: Chairman-Chemistry Department at the University of Oxford (2006), Chairman at OMass Therapeutics Ltd., Non-Executive Director at Oxeco Plc, Non-Executive Director at IP Group Plc (2012-2013), Director at Oxford University Innovation Ltd., Non-Executive Director at Tissue Regenix Group Plc (2006-2010), Director at TdeltaS Ltd., and Non-Executive Director at Crysalin Ltd.
Aktive Positionen von William Graham Richards
| Unternehmen | Position | Beginn |
|---|---|---|
Oxford Drug Design Ltd.
 Oxford Drug Design Ltd. Packaged SoftwareTechnology Services Develops software solutions used for computational methods to discover new leads for drugs | Gründer | 01.01.2001 |
Ehemalige bekannte Positionen von William Graham Richards
| Unternehmen | Position | Ende |
|---|---|---|
| IP GROUP PLC | Vorsitzender | 10.09.2009 |
Oxeco Plc
 Oxeco Plc Financial ConglomeratesFinance Provides investment services in the technology and science sectors | Direktor/Vorstandsmitglied | 30.06.2010 |
| TISSUE REGENIX GROUP LTD | Direktor/Vorstandsmitglied | 29.06.2010 |
University of Oxford
 University of Oxford Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 30.06.2006 |
o2h Ltd
 o2h Ltd Investment ManagersFinance O2h is an active manager which invests in EIS & SEIS companies located in the UK. The firm targets companies operating in the fields of pharmaceuticals, biotechnology, novel drug discovery, AI technologies, digital therapeutics and enabling services. It provides financing for seed and early stage capital requirements. | Berater | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
39
Beziehungen ersten Grades
11
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 11 |
|---|---|
Oxeco Plc
Oxeco Plc Financial ConglomeratesFinance Provides investment services in the technology and science sectors | Finance |
University of Oxford
University of Oxford Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Oxford Molecular Group Plc
 Oxford Molecular Group Plc Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals, chemicals,services in informatics and computation. | Health Technology |
IP Group Plc
 IP Group Plc Miscellaneous Commercial ServicesCommercial Services Operates as an intellectual property commercialization and venture capital fund management company | Commercial Services |
Oxford Drug Design Ltd.
Oxford Drug Design Ltd. Packaged SoftwareTechnology Services Develops software solutions used for computational methods to discover new leads for drugs | Technology Services |
Oxford University Innovation Ltd.
 Oxford University Innovation Ltd. Investment ManagersFinance Oxford University Innovation invests in spun out companies located in the United Kingdom. The firm targets companies operating in the fields of across a broad range of sectors and industries. It provides financing for seed and early-stage capital requirements. | Finance |
Tissue Regenix Group Plc
 Tissue Regenix Group Plc Medical SpecialtiesHealth Technology Operates as a medical devices company | Health Technology |
TdeltaS Ltd.
 TdeltaS Ltd. Miscellaneous Commercial ServicesCommercial Services Provides commercial, physical and biological research and development services | Commercial Services |
Crysalin Ltd.
 Crysalin Ltd. BiotechnologyHealth Technology Develops technology for protein structure determination | Health Technology |
OMass Therapeutics Ltd.
 OMass Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Develops native mass spectrometry platform | Commercial Services |
o2h Ltd
o2h Ltd Investment ManagersFinance O2h is an active manager which invests in EIS & SEIS companies located in the UK. The firm targets companies operating in the fields of pharmaceuticals, biotechnology, novel drug discovery, AI technologies, digital therapeutics and enabling services. It provides financing for seed and early stage capital requirements. | Finance |
